ResMed | RMD - Biaya Penjualan

Harga Saham
230.69
Perubahan Harian
0.43 0.19%
Bulanan
0.03%
Tahunan
7.81%
Q2 Perkiraan
222.62




Biaya Penjualan Perubahan Tanggal
Ansell USD 605.3M 351.2M 2025-12
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Baxter International USD 2.4B 512M 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
CSL USD 3.87B 2.08B 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Fisher Paykel Healthcare NZD 402.8M 15.2M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Haemonetics USD 136.58M 4.01M 2025-12
Hologic USD 463.7M 5.1M 2025-12
Idexx Laboratories USD 432.46M 10.58M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Philips EUR 2.81B 417M 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 555.85M 29.13M 2025-12
Sigma Healthcare AUD 1.55B 165.16M 2024-12
Sonic Healthcare AUD 751.66M 801.13M 2024-12
Steris USD 840.7M 26.3M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12